Documents to procure gamma irradiation chamber and license for operation in blood center.

IF 0.6 Q4 HEMATOLOGY
Asian Journal of Transfusion Science Pub Date : 2025-01-01 Epub Date: 2024-08-22 DOI:10.4103/ajts.ajts_208_23
Rakesh Kumar Luhar, Kishore Maheshwari, Ripal J Shah, V Harimoorthy
{"title":"Documents to procure gamma irradiation chamber and license for operation in blood center.","authors":"Rakesh Kumar Luhar, Kishore Maheshwari, Ripal J Shah, V Harimoorthy","doi":"10.4103/ajts.ajts_208_23","DOIUrl":null,"url":null,"abstract":"<p><p>Graft-versus-host disease is a critical posttransplant complication, particularly affecting individuals with compromised immune systems. Patients undergoing bone marrow transplants, neonates receiving intrauterine transfusions, and those recipients of blood from first-degree relatives are vulnerable to this condition. The significance of efficient lymphocyte inactivation has driven the widespread adoption of Gamma Irradiation Chambers (GICs) utilizing radiation sources such as Cesium-137 (Cs-137) or Cobalt-60 (Co-60). However, the effective operation of these chambers is contingent on navigating a complex regulatory landscape (Cs-137 or Co-60 is commonly used as the source of gamma rays. The usual dose is 25 Gray [Gy] to 35 Gy [1 Gy = 100 rads], this dosage inactivates 85%-95% of lymphocytes in the blood components without any adverse effect on other cellular components of the blood). GIC unit mainly houses either Co-60 or Cs-137as radiation sources (model no BI-2000, BI-5000 mfr. by Board of Radiation and Isotope Technology with typical radioactivity ranging from tens to hundreds of terabecquerel. These units are also used in research institutions, hospitals, blood center, etc. A review of legal, regulatory, and policy aspects of the operation of GIC in India regarding its issues, challenges, and opportunities. We aimed to prepare a standard guidance document for GIC for a smooth process of the Atomic Energy Regulatory Board (AERB) licensing and equipment purchasing. The present article was written based on the experience of applying for GIC with AERB and recurrent support extended to colleagues in the fraternity. The documents prepared for licensing and various procedural steps involved in the same are included. Many documents and many days are required from procurement to the receipt of the license for operation GIC. At the same time, with very few user institutes and less number of experienced people in the country, it becomes difficult to find a proper method to approach the national government body. If blood center/radiological safety officer are properly trained as per the guidelines available, this can reduce man-days and facilitate the earliest operations.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"19 1","pages":"177-180"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364036/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Transfusion Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ajts.ajts_208_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Graft-versus-host disease is a critical posttransplant complication, particularly affecting individuals with compromised immune systems. Patients undergoing bone marrow transplants, neonates receiving intrauterine transfusions, and those recipients of blood from first-degree relatives are vulnerable to this condition. The significance of efficient lymphocyte inactivation has driven the widespread adoption of Gamma Irradiation Chambers (GICs) utilizing radiation sources such as Cesium-137 (Cs-137) or Cobalt-60 (Co-60). However, the effective operation of these chambers is contingent on navigating a complex regulatory landscape (Cs-137 or Co-60 is commonly used as the source of gamma rays. The usual dose is 25 Gray [Gy] to 35 Gy [1 Gy = 100 rads], this dosage inactivates 85%-95% of lymphocytes in the blood components without any adverse effect on other cellular components of the blood). GIC unit mainly houses either Co-60 or Cs-137as radiation sources (model no BI-2000, BI-5000 mfr. by Board of Radiation and Isotope Technology with typical radioactivity ranging from tens to hundreds of terabecquerel. These units are also used in research institutions, hospitals, blood center, etc. A review of legal, regulatory, and policy aspects of the operation of GIC in India regarding its issues, challenges, and opportunities. We aimed to prepare a standard guidance document for GIC for a smooth process of the Atomic Energy Regulatory Board (AERB) licensing and equipment purchasing. The present article was written based on the experience of applying for GIC with AERB and recurrent support extended to colleagues in the fraternity. The documents prepared for licensing and various procedural steps involved in the same are included. Many documents and many days are required from procurement to the receipt of the license for operation GIC. At the same time, with very few user institutes and less number of experienced people in the country, it becomes difficult to find a proper method to approach the national government body. If blood center/radiological safety officer are properly trained as per the guidelines available, this can reduce man-days and facilitate the earliest operations.

Abstract Image

Abstract Image

采购伽马辐射室的文件和血液中心的操作许可证。
移植物抗宿主病是一种重要的移植后并发症,尤其影响免疫系统受损的个体。接受骨髓移植的患者、接受宫内输血的新生儿以及接受一级亲属血液的患者易患此病。高效淋巴细胞失活的重要性推动了伽马辐照室(gic)的广泛采用,利用放射源如铯-137 (Cs-137)或钴-60 (Co-60)。然而,这些腔室的有效运行取决于复杂的监管环境(Cs-137或Co-60通常用作伽马射线源)。通常剂量为25格雷[Gy]至35 Gy [1 Gy = 100拉德],此剂量可使血液成分中85%-95%的淋巴细胞失活,而对血液中的其他细胞成分无不良影响)。GIC单元主要容纳Co-60或Cs-137as辐射源(型号BI-2000、BI-5000 mfr)。辐射和同位素技术委员会,典型的放射性范围从几十到几百太贝克。这些装置也用于科研机构、医院、血液中心等。回顾GIC在印度运营的法律、监管和政策方面的问题、挑战和机遇。我们的目标是为GIC准备一份标准的指导文件,以便原子能监管委员会(AERB)许可和设备采购的顺利进行。这篇文章是根据我与AERB申请GIC的经验,以及对兄弟会同事的经常性支持而写的。包括为许可而准备的文件和其中涉及的各种程序步骤。从采购到收到运营GIC的许可证,需要很多文件和很多时间。与此同时,由于国内用户研究所很少,有经验的人也很少,因此很难找到与国家政府机构接触的适当方法。如果血液中心/放射安全官员按照现有的指导方针进行适当的培训,这可以减少工时并促进最早的操作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
56
审稿时长
44 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信